Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-14 Purchase |
2023-03-16 7:16 pm |
Rallybio Corp | RLYB | Lieber Jonathan I See Remarks |
5,000 | $5.21 | $26,050 | 5,000 (Direct) |
View |
| 2022-06-07 Purchase |
2022-06-08 3:12 pm |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
37,500 | $0.1871 | $7,016 | 37,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 7:27 pm |
N/A 2035-02-14 |
Rallybio Corp | RLYB | Lieber Jonathan I Chief Financial Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:21 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 6:20 pm |
N/A 2034-02-15 |
Rallybio Corp | RLYB | Lieber Jonathan I Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-01 6:33 pm |
N/A 2033-02-01 |
Rallybio Corp | RLYB | Lieber Jonathan I See Remarks |
240,000 | $0 | 240,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:12 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
1,440 | $0 | 2,940 (Direct) |
View |
| 2022-08-21 Option Award |
2022-08-24 8:04 pm |
N/A 2032-08-21 |
APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Lieber Jonathan I Chief Financial Officer |
154,700 | $0 | 154,700 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:10 pm |
2023-02-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-09-20 Option Award |
2021-09-21 9:25 pm |
N/A 2031-09-20 |
APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Lieber Jonathan I Chief Financial Officer |
202,000 | $0 | 202,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 4:59 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-07-14 Option Award |
2020-07-16 08:33 am |
N/A 2030-07-13 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
3,000 | $0 | 3,000 (Direct) |
View |